Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Baclofen in hemifacial spasm.

R Sandyk

    European Neurology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Baclofen, a medication for muscle spasms, provided significant relief for a patient with long-standing hemifacial spasm. The patient remained symptom-free for 12 months without adverse effects, suggesting potential therapeutic benefits.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Resolution of partial cataplexy in multiple sclerosis by treatment with weak electromagnetic fields.

    The International journal of neuroscience·1996
    Same author

    Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields.

    The International journal of neuroscience·1995
    Same author

    Reversal of visuospatial deficit on the Clock Drawing Test in Parkinson's disease by treatment with weak electromagnetic fields.

    The International journal of neuroscience·1995
    Same author

    Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields.

    The International journal of neuroscience·1995
    Same author

    Weak electromagnetic fields improve body image perception in patients with multiple sclerosis.

    The International journal of neuroscience·1995
    Same author

    Weak electromagnetic fields restore dream recall in patients with multiple sclerosis.

    The International journal of neuroscience·1995
    Same journal

    Combined Olfactory Testing and Substantia Nigra Hyperechogenicity for Diagnostic Differentiation of Parkinson's Disease.

    European neurology·2026
    Same journal

    The Role of Stroke Severity in the Association between Hypoperfusion Intensity Ratio and Futile Reperfusion after Endovascular Treatment.

    European neurology·2026
    Same journal

    The Parkinsonism of Salvador Dalí.

    European neurology·2026
    Same journal

    Disorders of Arousal and Sleep-Related Hypermotor Epilepsy in Adults: A Challenging but Necessary and Critical Distinctive Diagnosis.

    European neurology·2026
    Same journal

    Sex-Specific Phenotypic Characteristics in Obstructive Sleep Apnea: A Comprehensive Analysis of Anthropometric, Hematological, and Metabolic Profiles Stratified by Disease Severity.

    European neurology·2026
    Same journal

    Historical and Clinical Analysis of a Case of Progressive Muscular Atrophy (1853-1871).

    European neurology·2026
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Hemifacial spasm is a neurological disorder characterized by involuntary contractions of facial muscles.
    • Current treatment options for hemifacial spasm can have limitations or side effects.

    Observation:

    • A 58-year-old woman with chronic hemifacial spasm was treated with baclofen (Lioresal).
    • A daily dosage of 37.5 mg of baclofen was administered.

    Findings:

    • The patient experienced rapid and dramatic symptom relief within 48 hours of initiating baclofen treatment.
    • Symptomatic improvement was sustained for a 12-month treatment period.
    • No adverse events or toxic side effects were reported during the treatment duration.

    Implications:

    • Baclofen demonstrates potential as an effective treatment for hemifacial spasm.

    Related Experiment Videos

  • Further controlled clinical studies are warranted to validate these preliminary findings.
  • Baclofen may offer a well-tolerated therapeutic option for managing hemifacial spasm.